BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

Amber Louw, Oluf Dimitri Røe, Weronika Maria Szejniuk et al.|Journal of Thoracic Oncology|2022

Cited by 65